{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:52:48Z","timestamp":1763016768767},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T00:00:00Z","timestamp":1185753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T00:00:00Z","timestamp":1185753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.bmt.1705792","type":"journal-article","created":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T07:18:30Z","timestamp":1185779910000},"page":"651-658","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients"],"prefix":"10.1038","volume":"40","author":[{"given":"S","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"El Weshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Janabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Maghfoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,30]]},"reference":[{"key":"BF1705792_CR1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","volume":"327","author":"G Canellos","year":"1992","unstructured":"Canellos G, Anderson J, Propert K, Nissen N, Cooper M, Henderson E et al. Chemotherapy for advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478\u20131484.","journal-title":"N Engl J Med"},{"key":"BF1705792_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"D Linch","year":"1993","unstructured":"Linch D, Winfield D, Goldstone A, Moir D, Hancock B, McMillan A et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet 1993; 341: 1051\u20131054.","journal-title":"Lancet"},{"key":"BF1705792_CR3","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 2002; 359: 2065\u20132071.","journal-title":"Lancet"},{"key":"BF1705792_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1200\/JCO.1992.10.2.210","volume":"10","author":"D Longo","year":"1992","unstructured":"Longo D, Duffey P, Young R, Hubbard S, Ihde D, Glatstein E et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 1992; 10: 210\u2013218.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1200\/JCO.1997.15.2.528","volume":"15","author":"V Bonfante","year":"1997","unstructured":"Bonfante V, Santoro A, Viviani S, Devizzi L, Balzarotti M, Soncini F et al. Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol 1997; 15: 528\u2013534.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2004-12-4689","volume":"106","author":"JC Lavoie","year":"2005","unstructured":"Lavoie JC, Connors JM, Phillips GL, Reece DE, Barnett MJ, Forrest DL et al. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood 2005; 106: 1473\u20131478.","journal-title":"Blood"},{"key":"BF1705792_CR7","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/sj.bmt.1704508","volume":"33","author":"J Czyz","year":"2004","unstructured":"Czyz J, Szydlo R, Knopinska-Posluszny W, Hellmann A, Gozdzik J, Hansz J et al. Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy. Bone Marrow Transplant 2004; 33: 1225\u20131229.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705792_CR8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V96.4.1280","volume":"96","author":"A Josting","year":"2000","unstructured":"Josting A, Rueffer U, Franklin J, Sieber M, Diehl V, Engert A . Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood 2000; 96: 1280\u20131286.","journal-title":"Blood"},{"key":"BF1705792_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/annonc\/mdi119","volume":"16","author":"A Sureda","year":"2005","unstructured":"Sureda A, Constans M, Iriondo A, Arranz R, Caballero MD, Vidal MJ et al. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol 2005; 16: 625\u2013633.","journal-title":"Ann Oncol"},{"key":"BF1705792_CR10","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1200\/JCO.2004.02.121","volume":"22","author":"YE Lieskovsky","year":"2004","unstructured":"Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP et al. High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. J Clin Oncol 2004; 22: 4532\u20134540.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR11","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.1999.17.10.3101","volume":"17","author":"JW Sweetenham","year":"1999","unstructured":"Sweetenham JW, Carella AM, Taghipour G, Cunningham D, Marcus R, Della Volpe A et al. High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. J Clin Oncol 1999; 17: 3101\u20133109.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.1999.17.1.222","volume":"17","author":"M Andr\u00e9","year":"1999","unstructured":"Andr\u00e9 M, Henry-Amar M, Pico JL, Brice P, Blaise D, Kuentz M et al. Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case \u2013 control study Soci\u00e9t\u00e9 Francaise de Greffe de Moelle. J Clin Oncol 1999; 17: 222\u2013229.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1200\/JCO.1999.17.2.534","volume":"17","author":"HM Lazarus","year":"1999","unstructured":"Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 1999; 17: 534\u2013545.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1182\/blood.V86.2.451.bloodjournal862451","volume":"86","author":"DE Reece","year":"1995","unstructured":"Reece DE, Barnett MJ, Shepherd JD, Hogge DE, Klasa RJ, Nantel SH et al. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV+\/\u2212P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Blood 1995; 86: 451\u2013456.","journal-title":"Blood"},{"key":"BF1705792_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bmt.1703590","volume":"30","author":"J Czyz","year":"2002","unstructured":"Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Gozdzik J, Holowiecki J et al. High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group. Bone Marrow Transplant 2002; 30: 29\u201334.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705792_CR16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V89.3.814","volume":"89","author":"AR Yuen","year":"1997","unstructured":"Yuen AR, Rosenberg SA, Hoppe RT, Halpern JD, Horning SJ . Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 1997; 89: 814\u2013822.","journal-title":"Blood"},{"key":"BF1705792_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1705235","volume":"37","author":"F Morabito","year":"2006","unstructured":"Morabito F, Stelitano C, Luminari S, Mammi C, Marcheselli L, Callea V et al. The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL). Bone Marrow Transplant 2006; 37: 283\u2013288.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705792_CR18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","volume":"81","author":"R Chopra","year":"1993","unstructured":"Chopra R, McMillan AK, Linch DC, Yuklea S, Taghipour G, Pearce R et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 1993; 81: 1137\u20131145.","journal-title":"Blood"},{"key":"BF1705792_CR19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1182\/blood.V83.5.1161.1161","volume":"83","author":"PJ Bierman","year":"1994","unstructured":"Bierman PJ, Vose JM, Armitage JO . Autologous transplantation for Hodgkin's disease: coming of age? Blood 1994; 83: 1161\u20131164.","journal-title":"Blood"},{"key":"BF1705792_CR20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.V89.3.801","volume":"89","author":"SJ Horning","year":"1997","unstructured":"Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW et al. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Blood 1997; 89: 801\u2013813.","journal-title":"Blood"},{"key":"BF1705792_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","volume":"19","author":"A Sureda","year":"2001","unstructured":"Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, Garc\u00eda-Conde J et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espa\u00f1ol de Linfomas\/Transplante Aut\u00f3logo de M\u00e9dula Osea Spanish Cooperative Group. J Clin Oncol 2001; 19: 1395\u20131404.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR22","first-page":"467","volume":"20","author":"C Ferm\u00e9","year":"2002","unstructured":"Ferm\u00e9 C, Mounier N, Divin\u00e9 M, Brice P, Stamatoullas A, Reman O et al. Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. J Clin Oncol 2002; 20: 467\u2013475.","journal-title":"J Clin Oncol"},{"key":"BF1705792_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2141.2003.04828.x","volume":"124","author":"CH Moskowitz","year":"2004","unstructured":"Moskowitz CH, Kewalramani T, Nimer SD, Gonzalez M, Zelenetz AD, Yahalom J . Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease. Br J Haematol 2004; 124: 645\u2013652.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705792","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:42:55Z","timestamp":1648082575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,30]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF1705792"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705792","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,30]]},"assertion":[{"value":"8 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}